111
112
113
de Steur, W. O., van Amelsfoort, R. M., Hartgrink, H. H., Putter, H., Meershoek-Klein Kranenbarg, E., van Grieken, N. C.T., van Sandick, J. W., Claassen, Y. H.M., Braak, J. P.B.M., Jansen, E. P.M., Sikorska, K., van Tinteren, H., Walraven, I., Lind, P., Nordsmark, M., van Berge Henegouwen, M. I., van Laarhoven, H. W.M., Cats, A., Verheij, M., van de Velde, C. J.H.
Veröffentlicht in: de Steur , W O , van Amelsfoort , R M , Hartgrink , H H , Putter , H , Meershoek-Klein Kranenbarg , E , van Grieken , N C T , van Sandick , J W , Claassen , Y H M , Braak , J P B M , Jansen , E P M , Sikorska , K , van Tinteren , H , Walraven , I , Lind , P , Nordsmark , M , van Berge Henegouwen , M I , van Laarhoven , H W M , Cats , A , Verheij , M , van de Velde , C J H & CRITICS investigators 2021 , ' Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial ' , Annals of Oncology , vol. 32 , no. 3 , pp. 360-367 . https://doi.org/10.1016/j.annonc.2020.11.004;
2021
Veröffentlicht in: de Steur , W O , van Amelsfoort , R M , Hartgrink , H H , Putter , H , Meershoek-Klein Kranenbarg , E , van Grieken , N C T , van Sandick , J W , Claassen , Y H M , Braak , J P B M , Jansen , E P M , Sikorska , K , van Tinteren , H , Walraven , I , Lind , P , Nordsmark , M , van Berge Henegouwen , M I , van Laarhoven , H W M , Cats , A , Verheij , M , van de Velde , C J H & CRITICS investigators 2021 , ' Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial ' , Annals of Oncology , vol. 32 , no. 3 , pp. 360-367 . https://doi.org/10.1016/j.annonc.2020.11.004;
2021
114
Arena, Patrick J., Huang, Kui, Löfling, Lukas, Bahmanyar, Shahram, Mo, Jingping, Schachterle, Stephen E., Nunes, Anthony P., Smits, Elisabeth, Juuti, Rosa, Hoti, Fabian, Korhonen, Pasi, Adelborg, Kasper, Sundbøll, Jens, Rasmussen, Torben Riis, Løkke, Anders, Ehrenstein, Vera
Veröffentlicht in: Arena , P J , Huang , K , Löfling , L , Bahmanyar , S , Mo , J , Schachterle , S E , Nunes , A P , Smits , E , Juuti , R , Hoti , F , Korhonen , P , Adelborg , K , Sundbøll , J , Rasmussen , T R , Løkke , A & Ehrenstein , V 2023 , ' Validation of safety outcomes in routinely collected data : Lessons learned from a multinational postapproval safety study ' , Pharmacoepidemiology and Drug Safety , vol. 32 , no. 5 , pp. 592-596 . https://doi.org/10.1002/pds.5582;
2023
Veröffentlicht in: Arena , P J , Huang , K , Löfling , L , Bahmanyar , S , Mo , J , Schachterle , S E , Nunes , A P , Smits , E , Juuti , R , Hoti , F , Korhonen , P , Adelborg , K , Sundbøll , J , Rasmussen , T R , Løkke , A & Ehrenstein , V 2023 , ' Validation of safety outcomes in routinely collected data : Lessons learned from a multinational postapproval safety study ' , Pharmacoepidemiology and Drug Safety , vol. 32 , no. 5 , pp. 592-596 . https://doi.org/10.1002/pds.5582;
2023
115
116
117
118
119
120